You are here:
Programme policies are developed to set coherent principles for all Gavi-eligible countries and to guide specific decisions conducive to Gavi’s mission. These policies are approved by the Gavi Board and reviewed on a regular basis.
23 August 2016
Co-financing means that countries contribute to the cost of Gavi-supported vaccines by financing some of the required vaccine doses.
03 February 2015
Eligibility and Transition policy
Gavi supports the world's poorest countries. The Eligibility & Transition policy sets out the criteria that determine which countries are eligible to apply for different forms of Gavi support.
05 March 2013
Gavi policy on fragility and immunisation
In December 2012, the Gavi Board approved a policy that allows tailored approaches to be applied to fragile states and time-limited responses to be extended to countries in short-term emergency situations, with the aim to improve or protect immunisation systems in Gavi-supported countries. The policy enables Gavi to work with our partners to strengthen our focus on countries that require more intensive support and attention.
07 March 2011
Gavi has committed to increasing immunisation coverage by 1) supporting countries to overcome gender-related barriers to accessing immunisation services and 2) promoting equity of access and utilisation for all girls and boys, women and men to immunisation and related health services that respond to their different health needs.
21 September 2016
Health system and immunisation strengthening support framework
HSIS aims to help Gavi-supported countries reach every child today and in the future, regardless of geography, socioeconomic status, or gender-related barriers.
In June 2013, the Gavi Board reviewed the mechanism which allows the ranking of technically sound proposals from Gavi-eligible countries and the subsequent prioritisation of funding choices in case of insufficient resources.
01 October 2015
The risk policy forms the overarching framework for Gavi’s risk management approach. It is embedded in various structures and processes for risk monitoring, reporting and mitigation.
30 November 2016
Assuring quality vaccines and immunisation products for countries that procure their own products with Gavi funds.
01 April 2011
Transparency and accountability policy
If Gavi is to deliver on its mission, it must take some risk, and do everything possible to mitigate that risk. Donors realise this, but also rightly expect risks to be minimised and action to be taken when misuse is uncovered.
Vaccine donation policy
Donations of vaccines by industry to international organisations or to governments can bring benefits if properly managed, but also carry certain risks. Gavi only accepts vaccines donations under exceptional circumstances and requires both the manufacturer and recipient country to comply with a number of conditions.
16 September 2016
Saving Antibiotics So That Antibiotics Can Save Lives
Wall Street Journal
03 March 2015
Ebola vaccine research in Africa
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
Since 2007, countries have immunised 32 million children with a second dose of measles vaccine with Gavi support. Gavi- funded measles campaigns have helped vaccinate another 118 million children in countries at high risk of outbreaks.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2017
modal window here